Quality Metrics Public Meeting

The public meeting and draft guidance are intended to gain stakeholders’ perspective in various aspects of the development and planned implementation of a quality metrics program launched under the authority of section 704 of the Food, Drug, and Cosmetic Act (FD&C Act). The guidance includes an explanation of CDER and CBER approaches to collecting and using data to aid in ensuring that regulatory review, compliance, and inspection policies are based on state-of-the-art pharmaceutical science and that they support continuous improvement and innovation in the pharmaceutical manufacturing industry.  The program is intended to play an important role in 1) fulfilling section 510(h)(3) of the Act, which requires FDA to inspect drug establishments in accordance with a risk-based schedule; and 2) attempting to predict and potentially mitigate drug shortages.  The input from this public meeting will help inform potential revision of the draft guidance and the planned implementation of this program by FDA.


August 24, 2015


8:30 a.m. – 5:00 p.m.


FDA White Oak Campus
10903 New Hampshire Ave.
Building 31, Room 1503B/C (Great Room)
Silver Spring, MD 20993
(Information about arrival to FDA’s White Oak campus)

Registration to Attend the Workshop

Webcast Information


Recordings of Meeting:

Other Meeting Information

Page Last Updated: 08/26/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English